Table 4.
No of patients on mechanical ventilation | 42/48 |
Duration of mechanical ventilation | |
Overall | 21.1 days |
(0–85 days) | |
Patients with sepsis/ARDS | 27.7 days |
(5–56 days) | |
Nonseptic patients | 23.3 days |
(1–85 days) | |
Post-thoracic surgery | 15.8 days |
(1–28 days) | |
No. of patients only on noninvasive ventilation | 6/48 |
No. of patients treated for presumed HAP or | 25/48 (52%) |
HAP during or after detection of HSV | |
Methicillin-sensitive staphylococcus aureus | 4 |
Methicillin-resistant staphylococcus aureus | 3 |
Pseudomonas aerogunosa | 6 |
Klebsiella pneumoniae | 5 |
Enterobacter cloacae | 4 |
Stenotrophomonas maltophilia | 1 |
Beta-hemolytic streptococci | 1 |
Citrobacter freundi | 1 |
Overall mortality | 20/48 (42%) |
Mortality based on disease category | |
Sepsis/ARDS | 7/20 (35%) |
Nonseptic patients | 13/20 (65%) |
No. of patients requiring tracheostomy | 16/48 (33%) |
Discharge disposition in survivors | |
Home | 11/28 (39%) |
Skilled nursing facility | 17/28 (61%) |
HAP, hospital-acquired pneumonia; VAP, ventilator-associated pneumonia